Colgate-Palmolive (NYSE:CL) Shares Purchased by Integrated Investment Consultants LLC

Integrated Investment Consultants LLC grew its holdings in Colgate-Palmolive (NYSE:CL) by 369.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,566 shares of the company’s stock after purchasing an additional 10,676 shares during the quarter. Integrated Investment Consultants LLC’s holdings in Colgate-Palmolive were worth $1,408,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Covestor Ltd increased its stake in shares of Colgate-Palmolive by 26.9% in the 1st quarter. Covestor Ltd now owns 1,015 shares of the company’s stock worth $91,000 after acquiring an additional 215 shares during the last quarter. Bessemer Group Inc. raised its stake in Colgate-Palmolive by 69.2% during the first quarter. Bessemer Group Inc. now owns 43,475 shares of the company’s stock worth $3,915,000 after purchasing an additional 17,773 shares during the period. Lake Street Advisors Group LLC boosted its holdings in Colgate-Palmolive by 38.8% in the 1st quarter. Lake Street Advisors Group LLC now owns 4,930 shares of the company’s stock valued at $444,000 after purchasing an additional 1,377 shares during the last quarter. EP Wealth Advisors LLC grew its stake in shares of Colgate-Palmolive by 4.0% in the 1st quarter. EP Wealth Advisors LLC now owns 43,137 shares of the company’s stock valued at $3,884,000 after buying an additional 1,662 shares during the period. Finally, Advisors Asset Management Inc. increased its holdings in shares of Colgate-Palmolive by 263.2% during the 1st quarter. Advisors Asset Management Inc. now owns 27,126 shares of the company’s stock worth $2,443,000 after buying an additional 19,657 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 16.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 0.3 %

Shares of CL opened at $93.91 on Thursday. Colgate-Palmolive has a fifty-two week low of $75.39 and a fifty-two week high of $109.30. The company has a market capitalization of $76.73 billion, a PE ratio of 26.91, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The stock has a fifty day moving average of $98.56 and a two-hundred day moving average of $98.52. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.13%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CL shares. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. Finally, HSBC restated a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.